Bicara Therapeutics Inc. Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bicara Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q3 2025.
  • Bicara Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $1.97M, a 376% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Bicara Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.97M +$1.56M +376% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $2.24M Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $552K Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $690K +$77K +12.6% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $414K Sep 30, 2024 10-Q 2024-11-12
Q4 2023 $613K Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.